Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Advanced Biomed Inc.

  • RENO, Nevada
  • Public · NASDAQ: ADVB
  • 31 employees
$6.9MMarket cap
-$3.3MNet income
31Employees
ADVBNASDAQ
2025IPO

About Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Net income
-$3.3M
Total assets
$6.5M
Market cap
$6.9M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: ADVB

15-minute delayed · data by Polygon.io

Market cap
$6.9M
Open
Day range
Prev close
Volume
IPO date
Mar 6, 2025

Market data by Polygon.io · prices are 15-minute delayed

No reviews yet. Be the first to review Advanced Biomed Inc..

Write a review
Explore

Similar companies

Browse all →